Zusammenfassung
Das Peniskarzinom ist ein Plattenepithelkarzinom mit hoher Letalität im fortgeschrittenen Stadium. Es existieren nur wenige Daten aus relativ kleinen Serien zur systemischen Therapie. Die etablierten Therapieschemata sind gekennzeichnet durch hohe Toxizität und geringe Effektivität. Diese desolate Situation lässt sich nur durch systematische Studien mit neuen Therapieprotokollen ändern. Erste Ergebnisse mit neuen Substanzen sind durchaus Erfolg versprechend, gegenwärtig aber überwiegend auf die Darstellung einzelner Fälle beschränkt.
Abstract
Penile cancer is a squamous epithelial neoplasia with a very high mortality in advanced stages. Only few series with small patient numbers have addressed the systemic treatment of advanced penile carcinoma. Established regimens are characterized by high toxicity and poor efficacy. Due to the relative paucity of data, recommendations and guidelines on the treatment of metastatic penile carcinoma are vague. New approaches and large-scale studies that will allow better definition of adequate and more effective treatment options are needed. Encouraging results with newer chemotherapeutic agents are at present mainly anecdotal but are still encouraging.
Literatur
Dexeus FH, Logothetis CJ, Sella A et al. (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146(5): 1284–1287
Haas GP, Blumenstein BA, Gagliano RG et al. (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 161(6): 1823–1825
Corral DA, Sella A, Pettaway CA et al. (1998) Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 160(5): 1770–1774
Hakenberg OW, Nippgen JGW, Froehner M et al. (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98(6): 1225–1227
Solsona E, Algaba F, Horenblas S et al. (2004) EAU Guidelines on Penile Cancer. Eur Urol 46(1): 1–8
Pizzocaro G, Piva L (1998) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27(6b): 823–824
Shammas FV, Ous S, Fossa SD (1992) Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 147(3): 630–632
Long HJ (2007) 3rd Management of metastatic cervical cancer: review of the literature. J Clin Oncol 25(20): 2966–2974
Murdoch D (2007) Standard and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review. Curr Opin Oncol 19(3): 216–221
Joerger M, Warzinekb T, Klaeserc B et al. (2004) Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology 63(4): 778–780
Bermejo C, Busby J, Spiess P et al. (2007) Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 177(4): 1335–1338
Theodore C, Skoneczna I, Bodrogi I et al. (2008) A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol 19(7): 1304–1307
Kattan J, Culine S, Droz JP et al. (1993) Penile cancer chemotherapy: twelve years‘ experience at Institut Gustave-Roussy. Urology 42(5): 559–562
Hussein AM, Benedetto P, Sridhar KS (1990) Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 65(3): 433–438
Hakenberg OW, Wirth MP (1999) Issues in the treatment of penile carcinoma. A short review. Urol Int 62(4): 229–233
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Protzel, C., Klebingat, HJ. & Hakenberg, O. Zur Therapie des fortgeschrittenen Peniskarzinoms. Urologe 47, 1229–1232 (2008). https://doi.org/10.1007/s00120-008-1841-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-008-1841-z